Compare MDXH & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MDXH | EPM |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.0M | 158.2M |
| IPO Year | 2021 | 1996 |
| Metric | MDXH | EPM |
|---|---|---|
| Price | $2.30 | $4.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $7.67 | $4.93 |
| AVG Volume (30 Days) | 156.6K | ★ 431.6K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $43,229,621.00 |
| Revenue This Year | $30.78 | N/A |
| Revenue Next Year | $18.31 | N/A |
| P/E Ratio | ★ N/A | $93.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.36 | $3.19 |
| 52 Week High | $5.33 | $5.70 |
| Indicator | MDXH | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 18.64 | 53.61 |
| Support Level | $1.90 | $4.38 |
| Resistance Level | $2.30 | $4.63 |
| Average True Range (ATR) | 0.20 | 0.15 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 3.45 | 39.58 |
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.